Dr. Rick Abramson is Associate Director for Digital Health and Director of the Digital Health Center of Excellence within the Center for Devices and Radiological Health (CDRH) at the U.S. Food and Drug Administration (FDA).  In this role, he leads efforts to advance the development, evaluation, and regulation of digital health technologies, including artificial intelligence and software-based medical devices.

Dr. Abramson is a physician-executive with more than 20 years of experience at the intersection of healthcare delivery, technology, and policy.  Prior to joining FDA, he served as Global Chief Medical Officer at Annalise-AI, where he led global clinical and regulatory strategy.  He previously held senior leadership roles at Covera Health and HCA Healthcare.

Earlier in his career, Dr. Abramson was Associate Professor and Vice Chair for Innovation at Vanderbilt University Medical Center, where he practiced clinically and led NIH-funded research into machine learning and quantitative biomarkers for clinical trials.  He has also held roles in health policy and strategy at McKinsey & Company, the White House Office of Management and Budget, and Avalere.

Dr. Abramson received his undergraduate and medical degrees from Harvard University and a Master of Health Care Delivery Science from Dartmouth College.  He completed his postgraduate medical training at Brigham and Women’s Hospital, the University of Pennsylvania, and Johns Hopkins Hospital.  He is a Fellow of the American College of Radiology and has authored more than 80 peer-reviewed publications in medical imaging, healthcare quality measurement, and artificial intelligence.

Angela Krueger

Deputy Director for Regulatory Policy Office of Product Evaluation and Quality

U.S. Food and Drug Administration/ CDRH

Ms. Angela Krueger serves as the Deputy Director for Regulatory Policy for the Office of Product Evaluation and Quality (OPEQ), Center for Devices and Radiological Health (CDRH) at the US Food and Drug Administration (FDA). In this position, she provides executive leadership of OPEQ’s total product lifecycle (TPLC) evaluation of medical devices with a focus on regulatory policy issues. Ms. Krueger provides oversight and strategic direction for OPEQ’s policy, guidance, and regulation development and implementation teams, including in areas such as digital health, combination products, and device-specific policy. Ms. Krueger has worked at the FDA for over 20 years and has previously served in the former Office of Device Evaluation (ODE) as the Deputy Director for Engineering and Science and Associate Director for Regulations and Guidance; a Regulatory Advisor and Policy Analyst; CDRH Product Jurisdiction Officer; and a Scientific Reviewer in the Division of Cardiovascular Devices. Ms. Krueger holds degrees in Chemistry and Journalism from Butler University, Indianapolis, Indiana.

April leads the FDA/CDRH Total Product Life Cycle (TPLC) Advisory Program (TAP). Prior to her current role, April has served on the Obesity and Hepatobiliary Devices Team as the acting Assistant Director, Team Lead, Lead Reviewer, and chemistry consultant. In addition to supervisory, leadership, and medical device review responsibilities, April has promoted improvement in product manufacturing and quality through developing device specific FDA guidance documents, creating review tools to ensure consistency and quality in device review, and publishing external manuscripts on topics relevant to the FDA and industry on topics in the obesity and hepatobiliary device space. April has served as a Commissioner Fellowship Program (CFP) preceptor, mentor to new reviewers and advisors, and has developed and instructed Reviewer Certification Program courses. Prior to joining CDRH, April was a Commissioner Fellow at FDA’s National Center for Toxicology Research (NCTR) and served on the CFP Advisory Board. Prior to joining the FDA, April completed post-doctoral training at the University of Pittsburgh, Children’s Hospital of Pittsburgh and the Max Planck Institute for Biophysical Chemistry. April completed her doctoral training at the University of Central Florida’s National Center for Forensic Science.